Mark Stow

Discovery and Pharmacological Characterization of a Novel Rodent-Active CCR2 Antagonist, INCB3344

Carrie Brodmerkel, Reid Huber, Maryanne Covington et al. · The Journal of Immunology · 2005 · 188 citations

Life Sciences, Immunology, Pharmacology +17

Identification of ADAM10 as a major source of HER2 ectodomain sheddase activity in HER2 overexpressing breast cancer cells

Phillip C.C. Liu, Xiangdong Liu, Yanlong Li et al. · Cancer Biology & Therapy · 2006 · 186 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Safety and Immunogenicity of a Plant-Produced Recombinant Hemagglutinin-Based Influenza Vaccine (HAI-05) Derived from A/Indonesia/05/2005 (H5N1) Influenza Virus: A Phase 1 Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study in Healthy Adults

Jessica A. Chichester, R. Mark Jones, Brian J. Green et al. · Viruses · 2012 · 76 citations · Full text

Life Sciences, Biotechnology, Immunology +17

Large-Scale Expression, Refolding, and Purification of the Catalytic Domain of Human Macrophage Metalloelastase (MMP-12) in Escherichia coli

Ashfaq A. Parkar, Mark Stow, Keith Smith et al. · Protein Expression and Purification · 2000 · 34 citations

Life Sciences, Biochemistry, Molecular Biology +10

Antisense Oligonucleotides Selectively Regulate Aspartyl β-Hydroxylase and Its Truncated Protein Isoform in Vitro but Distribute Poorly into A549 Tumors in Vivo

Siew Peng Ho, Michael S. Scully, Candice Krauthauser et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 28 citations

Life Sciences, Cancer Biology, Molecular Biology +9